✦ LIBER ✦

Immunosuppressive effects of recombinant interferon-α during long-term treatment of cancer patients

✍ Scribed by Johannes V. Teichmann; Gerhard Sieber; Wolf-Dieter Ludwig; Hartmut Ruehl

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 509 KB
Volume: 63
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890515)63:10<1990::aid-cncr2820631020>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term effects of the treatment of po

Long-term effects of the treatment of polycythemia vera with recombinant interferon-α

✍ Richard T. Silver 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

Pharmacokinetics and biological activity

Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-γ in cancer patients

✍ W. Digel; G. Zahn; G. Heinzel; F. Porzsolt 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 741 KB

Low incidence of antibody formation due

Low incidence of antibody formation due to long-term interferon-?2c treatment of cancer patients

✍ Steinmann, G.G. ;G�d, B. ;Rosenkaimer, F. ;Adolf, G. ;Bidlingmaier, G. ;Fr�hbeis 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 592 KB

In order to study the long-term immunogenicity of interferon-alpha 2c (Berofor) in cancer patients, serum was collected starting in 1983 from study patients with various proliferative diseases who received interferon-alpha 2c at different doses, according to different schedules, and via different ro

Recombinant leukocyte a interferon (rIFN

Recombinant leukocyte a interferon (rIFN-αA) in the treatment of disseminated malignant melanoma: Analysis of complete and long-term responding patients

✍ Edward T. Creagan; David L. Ahmann; Stephen Frytak; Harry J. Long; Loretta M. It 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 1 views

Recombinant interferon α-2a in combinati

Recombinant interferon α-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients

✍ Ilan G. Ron; Moshe J. Inbar; Mordechai Gutman; Ofer Merimsky; Samario Chaitchik 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 987 KB

Long-term treatment with low doses of in

Long-term treatment with low doses of interleukin-2 and interferon-α: immunological effects in advanced renal cell cancer

✍ Laura Pavone; Simeone Andrulli; Rosaria Santi; Maria Majori; Carlo Buzio 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 184 KB